ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingHans‐Joachim Schmoll, Andrés Cervantes, Eric Van Cutsem et al.|Annals of Oncology|2012Cited by 1.5k
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Claus Rödel, Arthur Sun Myint et al.|Nature Reviews Clinical Oncology|2021Cited by 242
Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysisSami A. Chadi, Andrew G. Renehan, Lee Malcomson et al.|The Lancet. Gastroenterology & hepatology|2018Cited by 188
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancerT. H. van Dijk, Klaas Havenga, K Tamás et al.|Annals of Oncology|2013Cited by 147
EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: The radiology experts reviewVera Tudyka, Gina Brown, Lennart Blomqvist et al.|European Journal of Surgical Oncology|2013Cited by 95